Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHub and HyHub ...

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.

Gammagard Liquid is a prescription infusion used to help protect against infection and treat certain rare conditions. Learn about dosage, side effects, and more.

References 1. Jefferson M, Qi C, Narayanaswami P, et al. Changes in intravenous or subcutaneous immunoglobulin usage before and after efgartigimod initiation in patients with myasthenia gravis.

A subcutaneous injectable form of nivolumab is available to treat melanoma, non-small cell lung cancer, renal cell cancer, and many other cancers.

The role of nurses in transitioning from intravenous immunoglobulin (IVIG) to subcutaneous therapy in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) has been described in a new ...

Topline data were announced from a phase 2/3 trial evaluating immune globulin intravenous (human) in patients with post-polio syndrome.

Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial.

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors.

Takeda's HYQVIA is the first facilitated subcutaneous immunoglobulin therapy approved in Japan for agammaglobulinemia. HYQVIA offers less frequent dosing (every 3-4 weeks), improving patient ...

In the single-arm crossover substudy, patients received two intravenous treatment cycles followed by two subcutaneous cycles.